Ingevity (NGVT) Liabilities and Shareholders Equity (2015 - 2026)

Ingevity (NGVT) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $1.7 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 19.74% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 billion (down 18.14% YoY) and the FY2025 annual result came in at $1.7 billion, down 18.37% from the prior year.
• Liabilities and Shareholders Equity steadied at $1.7 billion in Q1 2026 per NGVT's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.8 billion in Q2 2023 and bottomed at $1.7 billion in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $2.3 billion (2022), against an average of $2.3 billion.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity climbed 19.54%; it then declined 22.9% in 2024.
• Tracing NGVT's Liabilities and Shareholders Equity over 5 years: stood at $2.7 billion in 2022, then decreased by 4.14% to $2.6 billion in 2023, then decreased by 22.9% to $2.0 billion in 2024, then dropped by 18.37% to $1.7 billion in 2025, then slipped by 0.05% to $1.7 billion in 2026.
• Per Business Quant, the three latest NGVT Liabilities and Shareholders Equity figures stand at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison